Laurence–Moon syndrome

Lore & Background

Laurence–Moon syndrome was first described in a paper published in 1866 by physicians John Zachariah Laurence and Robert Charles Moon. The syndrome is inherited in an autosomal recessive manner, meaning two copies of the defective gene are required for an individual to be born with the disorder. Parents of an affected individual each carry one copy of the defective gene but typically show no signs or symptoms.

Classic primary features of LMS include rod-cone dystrophy, spastic paraplegia, intellectual disability, and hypogonadism. Unlike Bardet–Biedl syndrome, polydactyly is not considered a primary feature of LMS, and no strict diagnostic criteria requiring a specific number of primary and secondary features have been established for LMS in authoritative medical sources. Secondary features such as brachydactyly, syndactyly, and polyuria/polydipsia are not standardly recognized for LMS.

There is no cure for Laurence–Moon syndrome, but symptomatic treatment is often provided. Patients frequently experience ataxia, spasticity, and contractures, which restrict movement and daily activities. A multidisciplinary approach is recommended, including physical therapy, psychiatric and ophthalmologic consultations, and nutrition management. Physical therapy aims to improve strength and mobility using assistive tools such as ankle-foot orthotic braces, weight-bearing walkers, and regular exercise.

Reader's Guide

Laurence–Moon syndrome holds significance as a rare genetic disorder that has been historically linked to Bardet–Biedl syndrome (BBS), with which it shares overlapping features. The syndrome was originally thought to have five cardinal features, later expanded to six, forming the basis of diagnostic criteria that require a combination of primary and secondary features. Recent advances in genetic typing have questioned whether LMS and BBS are genetically distinct. A 1999 epidemiological study reported that two patients clinically diagnosed as LMS had mutations in a BBS gene, and the features in that population did not support the notion that the two conditions are distinct. A 2005 paper further suggested that the two conditions are not separate. This ongoing uncertainty highlights the complexity of classifying phenotypically wide variations in patients. The legacy of Laurence–Moon syndrome lies in its contribution to the understanding of autosomal recessive disorders and the evolving genetic basis of syndromic conditions. The condition continues to be managed symptomatically through a multidisciplinary approach, emphasizing physical therapy, psychiatric and ophthalmologic care, and nutritional support.

Did You Know?

• Laurence–Moon syndrome is inherited in an autosomal recessive manner, requiring two copies of the defective gene.
• There is no cure for Laurence–Moon syndrome; treatment is symptomatic and multidisciplinary.